NUC-7738 Increases Apoptosis in Combination with Nivolumab–Relatlimab in Patient-Derived RCC Organoids (ESMO-IO 2026) - Oct 25, 2026 - Abstract #274P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • Combination therapy • Oncology • Renal Cell Carcinoma
|
|
Hazem Abdu llah; Anna E. Carberry; Alex Laird; Kathryn S. Kirkwood; In Hwa Um; P eter Mullen; David Harrison
|